Research Associate, Cancer Single Cell Biology

Perth, Australia
15 Dec 2017
End of advertisement period
22 Jan 2018
Academic Discipline
Life sciences, Biological Sciences
Contract Type
Fixed Term
Full Time

Faculty of Health and Medical Sciences

Harry Perkins Institute of Medical Research

  • Work with a consortium of cancer biologists, clinicians and bioinformaticians to study cancer at the single cell level
  • Full-time appointment on a 24 month fixed-term basis
  • Level A: $67,352 to $91,397 (plus 17% superannuation)

The University of Western Australia (UWA) is ranked amongst the top 100 universities in the world and a member of the prestigious Australian Group of Eight research-intensive universities. With an enviable research track record, vibrant campus and working environments, supported by the freedom to ‘innovate and inspire’ there is no better time to join Western Australia’s top University.

About the area: you will join the Faculty of Health and Medical Sciences based at the Harry Perkins Institute of Medical Research (Perkins) in Nedlands. With established links across the Western Australia health sector, this Centre provides teaching to undergraduate and postgraduate students across the medical disciplines. A core priority is medical and clinical research and a number of substantial research groups are based in the Centre’s laboratories.

The Cancer Research Trust has recently funded a nine year program to enable single cell approaches to study tumour biology. The program, led by Professor Alistair Forrest at the Harry Perkins Institute of Medical research, is based in Perth Western Australia and is a collaboration involving all major hospitals, medical research institutes and Universities in the region.

About the opportunity: as the Research Associate (cancer single cell biology) you will design and perform a wide variety of research laboratory tasks and experiments, making detailed observations, analysing data, and interpreting results with the help of supervisors. You will also develop reports, summaries, and protocols regarding experiments, as well as draft manuscripts for publication in scientific journals including generating the text and publication quality figures. In addition, you will perform troubleshooting of experiments and liaise closely with clinical and bioinformatic collaborators.

To be considered for this role, you will demonstrate:

  • A PhD or equivalent in molecular biology, cell biology, pathology and biochemistry with an emphasis in the specific fields of cancer biology, genomics, epigenetics, receptor-ligand signalling, systems biology or transcriptional regulation;
  • Experience in generating next generation sequencing libraries (for example ChIP-seq, RNA-seq, Cap Analysis of Gene Expression, Hi-C, single cell transcriptomes etc.);
  • Published articles using next generation sequencing data or in the broad area of tumour biology;
  • A demonstrated capacity to form hypotheses, test them and follow through to write papers;
  • Strong organisational skills and ability to meet deadlines; and
  • The ability to work as part of a multidisciplinary team.
  • Experience with patient samples, tissue dissociation, flow cytometry, cell culture, single cell profiling, immunohistochemistry and section in situ hybridization are all desirable skills.

Full details of the position’s responsibilities and the selection criteria are outlined in the position description. Applicants should demonstrate they meet the selection criteria by including a Cover Letter addressing the selection criteria specifically and a current CV including full listing of publications and contact information for three (3) professional referees.

For more information on this opportunity please contact Professor Alistair Forrest, Senior Principal Research Fellow on

Closing date: Monday, 22 January 2018 at 9am AWST

Application Details: Please apply online via the Apply Now button.

  • UWA has been awarded Top Ten Employer for LGBTI – inclusion the Australian Workplace Equity Index (AWEI -2016).
  • The University is also a proud member of the Athena SWAN/SAGE Pilot for Gender Equity.